American Bio Medica Corporation
ABMC
$0.00
$0.000.00%
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 1.88M | -317.00K | -314.00K | -400.00K | -379.00K |
| Total Depreciation and Amortization | 8.00K | 13.00K | 12.00K | 13.00K | 13.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.11M | -21.00K | -4.00K | -18.00K | 14.00K |
| Change in Net Operating Assets | -138.00K | -286.00K | 231.00K | 336.00K | 339.00K |
| Cash from Operations | -363.00K | -611.00K | -75.00K | -69.00K | -13.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 247.00K | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 247.00K | -- | -- | -- | -- |
| Total Debt Issued | 250.00K | 675.00K | 358.00K | 361.00K | 462.00K |
| Total Debt Repaid | -100.00K | -40.00K | -275.00K | -307.00K | -547.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 150.00K | 635.00K | 83.00K | 54.00K | -85.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.00K | 24.00K | 8.00K | -15.00K | -98.00K |